| $350M | ||
| $172M | ||
| $127M | ||
| $109M | ||
| $107M | ||
| $100M |
Buys | $98,808 | 1 | 4 |
Sells | $129,894,803 | 27 | 96 |
| Bodenstedt Matthias | Chief Financial Officer | 1 | $98,808 | 7 | $3.2M | $-3.1M |
| Reich Kristian | Chief Scientific Officer | 0 | $0 | 10 | $8.14M | $-8.14M |
| Santos da Silva Jorge | Chief Executive Officer | 0 | $0 | 7 | $8.73M | $-8.73M |
| Chen Bihua | Former 10% Owner | 0 | $0 | 2 | $46.87M | $-46.87M |
| BVF PARTNERS L P/IL | 0 | $0 | 1 | $62.96M | $-62.96M |
MoonLake Immunotherapeutics operates as a clinical-stage biopharmaceutical company, concentrating its efforts on discovering and developing novel therapies. The company's primary focus is the advancement of Sonelokimab, an innovative, investigational Nanobody-based treatment engineered to target inflammatory conditions. Currently, Sonelokimab is undergoing mid-stage (Phase II) clinical trials for a range of inflammatory diseases, including hidradenitis suppurativa, psoriatic arthritis, and both ankylosing spondylitis and radiographic axial spondyloarthritis. Established in 2021, MoonLake Immunotherapeutics is based in Zug, Switzerland.
Over the last 12 months, insiders at MoonLake Immunotherapeutics have bought $98,808 and sold $129.89M worth of MoonLake Immunotherapeutics stock.
On average, over the past 5 years, insiders at MoonLake Immunotherapeutics have bought $27.36M and sold $89.32M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Bodenstedt Matthias (Chief Financial Officer) — $98,808.
The last purchase of 10,870 shares for transaction amount of $98,808 was made by Bodenstedt Matthias (Chief Financial Officer) on 2025‑10‑08.
| 2026-07-27 | Sale | Reich Kristian | Chief Scientific Officer | 1,100 0.0013% | $20.00 | $22,000 | -17.15% | |
| 2026-07-22 | Sale | Reich Kristian | Chief Scientific Officer | 2,448 0.0031% | $20.00 | $48,960 | -12.65% | |
| 2026-07-21 | Sale | Reich Kristian | Chief Scientific Officer | 50,000 0.0604% | $20.02 | $1M | -17.30% | |
| 2026-07-20 | Sale | Reich Kristian | Chief Scientific Officer | 43,700 0.0558% | $20.09 | $877,933 | -12.52% | |
| 2026-07-15 | Sale | Reich Kristian | Chief Scientific Officer | 16,105 0.0195% | $20.01 | $322,261 | -13.68% | |
| 2026-07-10 | Sale | Santos da Silva Jorge | Chief Executive Officer | 68,289 0.0912% | $20.02 | $1.37M | -14.71% | |
| 2026-07-09 | Sale | Santos da Silva Jorge | Chief Executive Officer | 33,936 0.0463% | $20.01 | $679,059 | -12.69% | |
| 2026-07-01 | Sale | Santos da Silva Jorge | Chief Executive Officer | 47,775 0.068% | $20.03 | $956,933 | -6.01% | |
| 2026-06-22 | Sale | Bodenstedt Matthias | Chief Financial Officer | 39,120 0.0529% | $22.04 | $862,205 | -16.79% | |
| 2026-06-18 | Sale | Bodenstedt Matthias | Chief Financial Officer | 2,794 0.0039% | $19.60 | $54,762 | -3.31% | |
| 2026-06-17 | Sale | Reich Kristian | Chief Scientific Officer | 50,000 0.0695% | $19.43 | $971,500 | -2.50% | |
| 2026-06-17 | Sale | Bodenstedt Matthias | Chief Financial Officer | 15,082 0.021% | $19.68 | $296,814 | -2.50% | |
| 2026-06-16 | Sale | Reich Kristian | Chief Scientific Officer | 50,000 0.0669% | $18.70 | $935,000 | -0.97% | |
| 2026-06-15 | Sale | Reich Kristian | Chief Scientific Officer | 50,000 0.0669% | $18.89 | $944,500 | -1.62% | |
| 2026-05-11 | Sale | Bodenstedt Matthias | Chief Financial Officer | 13,653 0.0199% | $20.02 | $273,333 | -2.39% | |
| 2026-04-14 | Sale | Bodenstedt Matthias | Chief Financial Officer | 2,426 0.0034% | $19.56 | $47,453 | -4.02% | |
| 2026-04-13 | Sale | Santos da Silva Jorge | Chief Executive Officer | 51,873 0.0679% | $18.23 | $945,645 | -2.17% | |
| 2026-04-10 | Sale | Santos da Silva Jorge | Chief Executive Officer | 98,127 0.1298% | $18.41 | $1.81M | +0.84% | |
| 2026-04-10 | Sale | Bodenstedt Matthias | Chief Financial Officer | 1,925 0.0027% | $19.51 | $37,557 | +0.84% | |
| 2026-04-09 | Sale | Bodenstedt Matthias | Chief Financial Officer | 85,870 0.1328% | $18.94 | $1.63M | -7.11% |
| Santos da Silva Jorge | Chief Executive Officer | 2774893 3.2989% | $41.65M | 0 | 14 | |
| Reich Kristian | Chief Scientific Officer | 2711198 3.2232% | $40.7M | 0 | 17 | |
| Chen Bihua | Former 10% Owner | 1994173 2.3708% | $29.93M | 8 | 2 | <0.0001% |
| Bodenstedt Matthias | Chief Financial Officer | 1115435 1.3261% | $16.74M | 1 | 9 | |
| BVF PARTNERS L P/IL | 1039238 1.2355% | $15.6M | 0 | 2 | ||
| Helix Holdings LLC | 430000 0.5112% | $6.45M | 1 | 0 | <0.0001% | |
| Sturge Simon | director | 171980 0.2045% | $2.58M | 0 | 1 | |
| Moukheibir Catherine | director | 0 0% | $0 | 0 | 1 |
$831,902,292 | 108 | 9.34% | $1.3B | |
$100,473,344 | 83 | 9.53% | $1.21B | |
$15,410,062 | 81 | 39.69% | $1.1B | |
$276,808,393 | 17 | -6.69% | $1.17B | |
$11,845,103 | 12 | 14.43% | $1.18B | |
$2,314,489 | 11 | -0.78% | $1.37B | |
$186,141,911 | 11 | -8.72% | $1.23B | |
$1,229,070 | 10 | 23.53% | $1.37B | |
$140,543,039 | 10 | 0.77% | $1.29B | |
MoonLake Immunotherapeutics (MLTX) | $117,959,652 | 9 | -12.47% | $1.26B |
$38,624,786 | 9 | 1.26% | $1.36B | |
$49,165,200 | 7 | 12.92% | $1.26B | |
$19,683,752 | 7 | 6.05% | $1.33B | |
$112,382,168 | 4 | -48.89% | $1.36B | |
$25,999,974 | 4 | 0.00% | $1.44B | |
$704,400 | 2 | -29.92% | $1.07B | |
$12,750 | 2 | -39.73% | $1.01B | |
$44,400 | 1 | 49.80% | $1.21B | |
$13,900 | 1 | -39.25% | $1.02B |
| Increased Positions | 105 | +68.63% | 27M | +71.56% |
| Decreased Positions | 74 | -48.37% | 9M | -22.9% |
| New Positions | 50 | New | 14M | New |
| Sold Out Positions | 50 | Sold Out | 7M | Sold Out |
| Total Postitions | 184 | +20.26% | 56M | +48.66% |
| Bvf Inc/Il | $236,028.00 | 27.82% | 19.75M | 0 | 0% | 2025-09-30 |
| Avoro Capital Advisors Llc | $23,900.00 | 2.82% | 2M | -2M | -51.81% | 2025-09-30 |
| Cormorant Asset Management, Lp | $23,830.00 | 2.81% | 1.99M | -6M | -76.52% | 2025-09-30 |
| Balyasny Asset Management L.P. | $20,306.00 | 2.39% | 1.7M | +1M | +301.55% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $17,925.00 | 2.11% | 1.5M | +2M | New | 2025-09-30 |
| Schonfeld Strategic Advisors Llc | $11,537.00 | 1.36% | 965,405 | +965,405 | New | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $9,834.00 | 1.16% | 822,957 | -2M | -68.51% | 2025-09-30 |
| Fmr Llc | $8,687.00 | 1.02% | 726,932 | -5M | -87.31% | 2025-09-30 |
| Nuveen, Llc | $7,597.00 | 0.9% | 635,699 | -155,856 | -19.69% | 2025-09-30 |
| Two Sigma Investments, Lp | $5,429.00 | 0.64% | 454,268 | +454,268 | New | 2025-09-30 |